264
Views
49
CrossRef citations to date
0
Altmetric
Review

Atypical teratoid rhabdoid tumors of childhood: diagnosis, treatment and challenges

Pages 907-915 | Published online: 10 Jan 2014

References

  • Lefkowitz I, Rorke LB, Packer RJ et al. Atypical teratoid tumor of infancy: definition of an entity. Ann. Neurol. 22, 448–449 (1987).
  • Rorke LB, Packer R, Biegel J. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. J. Neurooncol. 24(1), 21–28 (1995).
  • Rorke, LB, Packer RJ, Biegel JA. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J. Neurosurg. 85(1), 56–65 (1996).
  • Burger C, Yu IT, Tihan T et al. Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. Am. J. Surg. Pathol. 22(9), 1083–1092 (1998).
  • Tekautz TM, Fuller CE, Blaney S et al. Atypical teratoid/rhabdoid tumors (atrt): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J. Clin. Oncol. 23(7), 1491–1499 (2005).
  • Bhattacharjee M, Hicks J, Langford L et al. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. Ultrastruct. Pathol. 21(4), 369–378 (1997).
  • Ho DM, Hsu CY, Wong TT, Ting LT, Chiang H. Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma. Acta Neuropathol. 99(5), 482–488 (2000).
  • Oka H, Scheithauer BW. Clinicopathological characteristics of atypical teratoid/rhabdoid tumor. Neurol. Med. Chir. 39(7), 510–518 (1999).
  • Dang T, Vassilyadi M, Michaud J et al. Atypical teratoid/rhabdoid tumors. Childs Nerv. Syst. 19(4), 244–248 (2003).
  • Beckwith JB. Wilms’ tumor and other renal tumors of childhood: a selective review from the National Wilms’ Tumor Study Pathology Center. Hum. Pathol. 14(6), 481–492 (1983).
  • Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumors: results from the First National Wilms’ Tumor Study. Cancer 41(5), 1937–1948 (1978).
  • Parham DM, Weeks DA, Beckwith JB. The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. An analysis of 42 cases studied with immunohistochemistry or electron microscopy. Am. J. Surg. Pathol. 18(10), 1010–1029 (1994).
  • Bannykh SI, Perry A, Powell HC et al. Malignant rhabdoid meningioma arising in the setting of preexisting ganglioglioma: a diagnosis supported by fluorescence in situ hybridization. Case report. J. Neurosurg. 97(6), 1450–1455 (2002).
  • Wyatt-Ashmead J, Kleinschmidt-DeMasters BK, Hill DA et al. Rhabdoid glioblastoma. Clin. Neuropathol. 20(6), 248–255 (2001).
  • Hauser P, Slowik F, Bognar L, Babosa M, Fazekas I, Schuler D. Atypical teratoid/rhabdoid tumor or medulloblastoma? Med. Pediatr. Oncol. 36(6), 644–648 (2001).
  • Ronghe MD, Moss TH, Lowis S. Treatment of CNS malignant rhabdoid tumors. Pediatr. Blood Cancer 42(3), 254–260 (2004).
  • Weiss E, Behring B, Behnke J, Christen HJ, Pekrun A, Hess CF. Treatment of primary malignant rhabdoid tumor of the brain: report of three cases and review of the literature. Int. J. Radiat. Oncol. Biol. Phys. 41(5), 1013–1019 (1998).
  • Olson TA, Bayar E, Kosnik E et al. Successful treatment of disseminated central nervous system malignant rhabdoid tumor. J. Pediatr. Hematol. Oncol. 17(1), 71–75 (1995).
  • Bhattacharjee M, Hicks J, Dauser R et al. Primary malignant rhabdoid tumor of the central nervous system. Ultrastruct. Pathol. 21(4), 361–368 (1997).
  • Reinhardt D, Behnke-Mursch J, Weiss E et al. Rhabdoid tumors of the central nervous system. Childs Nerv. Syst. 16(4), 228–234 (2000).
  • Fisher BJ, Siddiqui J, MacDonald D et al. Malignant rhabdoid tumor of brain: an aggressive clinical entity. Can. J. Neurol. Sci. 23(4), 257–263 (1996).
  • Brown HG, Kepner JL, Perlman EJ et al. ‘Large cell/anaplastic’ medulloblastomas: a Pediatric Oncology Group Study. J. Neuropathol. Exp. Neurol. 59(10), 857–865 (2000).
  • Biegel JA, Fogelgren B, Wainwright LM, Zhou JY, Bevan H, Rorke LB. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor. Genes Chromosomes Cancer 28(1), 31–37 (2000).
  • Chou SM, Anderson JS. Primary CNS malignant rhabdoid tumor (MRT): report of two cases and review of literature. Clin. Neuropathol. 10(1), 1–10 (1991).
  • Gonzalez-Crussi F, Goldschmidt RA, Hsueh W, Trujillo YP. Infantile sarcoma with intracytoplasmic filamentous inclusions: distinctive tumor of possible histiocytic origin. Cancer 49(11), 2365–2375 (1982).
  • Biggs J, Garen PD, Powers JM, Garvin AJ. Malignant rhabdoid tumor of the central nervous system. Hum. Pathol. 18(4), 332–337 (1987).
  • Frierson HF Jr, Mills SE, Innes DJ Jr. Malignant rhabdoid tumor of the pelvis. Cancer 55(9), 1963–1967 (1985).
  • Ota S, Crabbe DC, Tran TN, Triche TJ, Shimada H. Malignant rhabdoid tumor. A study with two established cell lines. Cancer 71(9), 2862–2872 (1993).
  • Judkins AR, Mauger J, Rorke LB, Biegel JA. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am. J. Surg. Pathol. 28(5), 644–650 (2004).
  • Burger PC, Shibata T, Kleihues P. The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am. J. Surg. Pathol. 10(9), 611–617 (1986).
  • Pollack IF, Hamiltoon RL, Burnham J et al. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort. Neurosurgery 50(6), 1238–1245 (2002).
  • Bowers DC, Gargan L, Kapur P et al. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents. J. Clin. Oncol. 21(15), 2968–2973 (2003).
  • Wakimoto H, Aoyagi M, Nakayama T et al. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer 77(2), 373–380 (1996).
  • Ho DM, Hsu CY, Ting LT, Chiang H. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 94(5), 1538–1547 (2002).
  • Ritter AM, Hess KR, McLendon RE, Langford LA. Ependymomas: MIB-1 proliferation index and survival. J. Neurooncol. 40(1), 51–57 (1998).
  • Biegel JA, Rorke LB, Packer RJ, Emanuel BS. Monosomy 22 in rhabdoid or atypical tumors of the brain. J. Neurosurg. 73(5), 710–714 (1990).
  • Lopez-Gines C, Cerda-Nicolas M, Kepes J, Donat J, Gil-Benso R, Llombart-Bosch A. Complex rearrangement of chromosomes 6 and 11 as the sole anomaly in atypical teratoid/rhabdoid tumors of the central nervous system. Cancer Genet. Cytogenet. 122(2), 149–152 (2000).
  • Biegel JA. Genetics of pediatric central nervous system tumors. J. Pediatr. Hematol. Oncol. 19(6), 492–501 (1997).
  • Biegel JA. Cytogenetics and molecular genetics of childhood brain tumors. Neurooncol. 1(2), 139–151 (1999).
  • Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin. Cancer Res. 8(11), 3461–3467 (2002).
  • Versteege I, Sevenet N, Lange J et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394(6689), 203–206 (1998).
  • Weber M, Stockhammer F, Schmitz U, von Deimling A. Mutational analysis of INI1 in sporadic human brain tumors. Acta Neuropathol. 101(5), 479–482 (2001).
  • Sevenet N, Lellouch-Tubiana A, Schofield D et al. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum. Mol. Genet. 8(13), 2359–2368 (1999).
  • Gessi M, Giangaspero F, Pietsch T. Atypical teratoid/rhabdoid tumors and choroid plexus tumors: when genetics ‘surprise’ pathology. Brain Pathol. 13(3), 409–414 (2003).
  • Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 59(1), 74–79 (1999).
  • Fujisawa H, Takabatake Y, Fukusato T, Tachibana O, Tsuchiya Y, Yamashita J. Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification. J. Neurooncol. 63(3), 257–262 (2003).
  • Sevenet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am. J. Hum. Genet. 65(5), 1342–1348 (1999).
  • Taylor MD, Gokgoz N, Andrulis IL, Mainprize TG, Drake JM, Rutka JT. Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. Am. J. Hum. Genet. 66(4), 1403–1406 (2000).
  • Packer RJ, Biegel JA, Blaney S et al. Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop. J. Pediatr. Hematol. Oncol. 24(5), 337–342 (2002).
  • Lutterbach J, Liegibel J, Koch D, Madlinger A, Frommhold H, Pagenstecher A. Atypical teratoid/rhabdoid tumors in adult patients: case report and review of the literature. J. Neurooncol. 52(1), 49–56 (2001).
  • Pimentel J, Silva R, Pimentel T. Primary malignant rhabdoid tumors of the central nervous system: considerations about two cases of adulthood presentation. J. Neurooncol. 61(2), 121–126 (2003).
  • Arrazola J, Pedrosa I, Mendez R, Saldana C, Scheithauer BW, Martinez A. Primary malignant rhabdoid tumour of the brain in an adult. Neuroradiology 42(5), 363–367 (2000).
  • Proust F, Laquerriere A, Constantin B, Ruchoux MM, Vannier JP, Freger P. Simultaneous presentation of atypical teratoid/rhabdoid tumor in siblings. J. Neurooncol. 43(1), 63–70 (1999).
  • Lee HY, Yoon C-S, Sevenet N et al. Rhabdoid tumor of the kidney is a component of the rhabdoid predisposition syndrome. Pediatr. Dev. Pathol. 5(4), 395–399 (2002).
  • Izycka-Swieszewska E, Debiec-Rychter M, Wasag B et al. A unique occurrence of a cerebral atypical teratoid/rhabdoid tumor in an infant and a spinal canal primitive neuroectodermal tumor in her father. J. Neurooncol. 61(3), 219–225 (2003).
  • Hilden JM, Meerbaum S, Burger P et al. Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J. Clin. Oncol. 22(14), 2877–2884 (2004).
  • Korones DN, Meyers SP, Rubio A, Torres C, Constine LS. A 4-year-old girl with a ventriculoperitoneal shunt metastasis of a central nervous system atypical teratoid/rhabdoid tumor. Med. Pediatr. Oncol. 32(5), 389–391 (1999).
  • Savla J, Chen TT, Schneider NR, Timmons CF, Delattre O, Tomlinson GE. Mutations of the hSNF5/INI1 gene in renal rhabdoid tumors with second primary brain tumors. J. Natl Cancer Inst. 92(8), 648–650 (2000).
  • Cohn RD, Frank Y, Stanek AE, Kalina P. Malignant rhabdoid tumor of the brain and kidney in a child: clinical and pathologic features. Pediatr. Neurol. 13(1), 65–68 (1995).
  • Bonnin JM, Rubinstein LJ, Palmer NF, Beckwith JB. The association of embryonal tumors originating in the kidney and in the brain. A report of seven cases. Cancer 54(10), 2137–2146 (1984).
  • Weeks DA, Beckwith JB, Mierau GW, Zuppan CW. Renal neoplasms mimicking rhabdoid tumor of kidney. A report from the National Wilms’ Tumor Study Pathology Center. Am. J. Surg. Pathol. 15(11), 1042–1054 (1991).
  • Zuccoli G, Izzi G, Bacchini E, Tondelli MT, Ferrozzi F, Bellomi M. Central nervous system atypical teratoid/rhabdoid tumour of infancy. CT and MR findings. Clin. Imaging 23(6), 356–360 (1999).
  • Huisman TA, Brandner S, Niggli F, Betts DR, Boltshauser E, Martin E. Malignant rhabdoid tumor of the brain: quantitative 1H MR-spectroscopy and cytogenetics. Neuropediatrics 31(3), 159–161 (2000).
  • Caldemeyer KS, Smith RR, Azzarelli B, Boaz JC. Primary central nervous system malignant rhabdoid tumor: CT and MR appearance simulates a primitive neuroectodermal tumor. Pediatr. Neurosurg. 21(4), 232–236 (1994).
  • Bambakidis NC, Robinson S, Cohen M, Cohen AR. Atypical teratoid/rhabdoid tumors of the central nervous system: clinical, radiographic and pathologic features. Pediatr. Neurosurg. 37(2), 64–70 (2002).
  • Fenton LZ, Foreman NK. Atypical teratoid/rhabdoid tumor of the central nervous system in children: an atypical series and review. Pediatr. Radiol. 33(8), 554–558 (2003).
  • Satoh H, Goishi J, Sogabe T, Uozumi T, Kiya K, Migita K. Primary malignant rhabdoid tumor of the central nervous system: case report and review of the literature. Surg. Neurol. 40(5), 429–434 (1993).
  • Inenaga C, Toyoshima Y, Mori H, Nishiyama K, Tanaka R, Takahashi H. A fourth ventricle atypical teratoid/rhabdoid tumor in an infant. Brain Tumor Pathol. 20(2), 47–52 (2003).
  • Hasserjian R, Folkerth RD, Scott RM, Schofield DE. Clinicopathologic and cytogenetic analysis of malignant rhabdoid tumor of the central nervous system. J. Neurooncol. 25(3), 193–203 (1995).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.